Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STREAM-2: Pharmaco-invasive Strategy vs Primary PCI in Elderly STEMI
NCT02777580Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Aug 2017
- Primary completion
- Oct 2022
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 10
01
Overview
A Phase 4 trial of tenecteplase in ST elevation myocardial infarction (STEMI), sponsored by KU Leuven. Started Aug 2017; status: completed.
02
Drugs
tenecteplase
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02777580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02777580.